TR200000157T2 - Nitrik oksit rhinovirüsün bulaşmasını önler. - Google Patents

Nitrik oksit rhinovirüsün bulaşmasını önler.

Info

Publication number
TR200000157T2
TR200000157T2 TR2000/00157T TR200000157T TR200000157T2 TR 200000157 T2 TR200000157 T2 TR 200000157T2 TR 2000/00157 T TR2000/00157 T TR 2000/00157T TR 200000157 T TR200000157 T TR 200000157T TR 200000157 T2 TR200000157 T2 TR 200000157T2
Authority
TR
Turkey
Prior art keywords
nitric oxide
rhinovirus
transmission
oxide prevents
cytokinesis
Prior art date
Application number
TR2000/00157T
Other languages
English (en)
Inventor
P. Sanders Scherer
Proud David
Original Assignee
The Johns Hopkins University School Of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Johns Hopkins University School Of Medicine filed Critical The Johns Hopkins University School Of Medicine
Publication of TR200000157T2 publication Critical patent/TR200000157T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Nitrik Oksit olusturan ya da Nitrik Oksit ile ilgili in situ sentezler meydana getiren bilesikler rinovirüs enfeksiyonlarinin inhibe edilmesinde kullanilabilir. Nitrik Oksit özellikle pro-enflamatuar sitokinez sirasinda, sitokinez sentezi de dahil olmak üzere viral replikasyonlari inhibe eden bir yetenege sahiptir. Buna ragmen, solunum yollarindaki nitrik oksidi arttirmak için yapilan tedavilerle rinovirüs enfeksiyonlari ile ilgili semptomlar iyilestirilebilir.
TR2000/00157T 1997-07-11 1998-07-10 Nitrik oksit rhinovirüsün bulaşmasını önler. TR200000157T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5230797P 1997-07-11 1997-07-11

Publications (1)

Publication Number Publication Date
TR200000157T2 true TR200000157T2 (tr) 2001-06-21

Family

ID=21976738

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00157T TR200000157T2 (tr) 1997-07-11 1998-07-10 Nitrik oksit rhinovirüsün bulaşmasını önler.

Country Status (14)

Country Link
US (1) US6277891B1 (tr)
EP (1) EP1011657A1 (tr)
JP (1) JP2001509481A (tr)
KR (1) KR20010021749A (tr)
CN (1) CN1277552A (tr)
AU (1) AU8399098A (tr)
BR (1) BR9811473A (tr)
CA (1) CA2303430A1 (tr)
CZ (1) CZ200092A3 (tr)
HU (1) HUP0002859A2 (tr)
ID (1) ID23780A (tr)
NO (1) NO20000151L (tr)
TR (1) TR200000157T2 (tr)
WO (1) WO1999002148A1 (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030753A1 (es) * 2000-09-25 2003-09-03 Smithkline Beecham Corp Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
DE10303196A1 (de) * 2003-01-28 2004-08-12 Märtz, Hans Helmut Verwendung von Erzeugnissen, Stoffen oder Stoffgemischen, aus welchen im menschlichen oder tierischen Körper Stickoxid (Formel: NO) entsteht, zur Behandlung oder Prophylaxe von Infektionskrankheiten des menschlichen oder tierischen Körpers
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
ES2294543T3 (es) 2003-07-09 2008-04-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Heal Uso de sales de nitrilo para el tratamiento de afecciones cardiovasculares.
US8252591B2 (en) 2004-05-07 2012-08-28 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US8557300B2 (en) 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
US20110244502A1 (en) 2007-08-10 2011-10-06 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
CA2710349A1 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
DK2276505T3 (da) * 2008-03-20 2013-11-25 Krister Tano Næsespray eller næsedråber til behandling af forkølelse
US11850283B2 (en) * 2017-06-27 2023-12-26 Ohio State Innovation Foundation Liponucleotide-based therapy for asthma
CN109432122A (zh) * 2018-11-19 2019-03-08 罗辉 No或no供体在制备预防和/或治疗皮肤疾病或黏膜疾病药物中的应用及药物组合物
CN109846113A (zh) * 2018-11-29 2019-06-07 南京诺全生物医疗科技有限公司 一种可自提供一氧化氮的口鼻卫生用品

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455279A (en) 1991-04-19 1995-10-03 The Children's Medical Center Corporation Regimen method of mediating neuronal damage using nitroglycerine

Also Published As

Publication number Publication date
ID23780A (id) 2000-05-11
JP2001509481A (ja) 2001-07-24
CN1277552A (zh) 2000-12-20
US6277891B1 (en) 2001-08-21
CA2303430A1 (en) 1999-01-21
HUP0002859A2 (hu) 2001-01-29
NO20000151D0 (no) 2000-01-11
BR9811473A (pt) 2001-12-26
KR20010021749A (ko) 2001-03-15
AU8399098A (en) 1999-02-08
EP1011657A1 (en) 2000-06-28
CZ200092A3 (en) 2001-05-16
WO1999002148A1 (en) 1999-01-21
NO20000151L (no) 2000-03-09

Similar Documents

Publication Publication Date Title
TR200000157T2 (tr) Nitrik oksit rhinovirüsün bulaşmasını önler.
TR200102799T2 (tr) Kemokin alıcı bağlayıcı heterosiklik bileşikler
TR200003635T2 (tr) Peg-IFN-ALFA ve ribavirinin kronik hepatit C tedavisinde kullanılması.
TR200102401T2 (tr) C-21 Değiştirilmiş epotilonlar.
TR200901979T2 (tr) Antikolinerjik etkili bileşik ve ?-mimetikler bazında yeni ilaç bileşimleri.
MY135721A (en) Amidino compounds useful as nitric oxide synthase inhibitors
ATE320457T1 (de) Polyurethanlösungen mit alkoxysilanstruktureinheiten
PT1315520E (pt) Utilizacao de anticorpos trifuncionais biespecificos e triespecificos para tratamento de ascites malignas
TR200102026T2 (tr) Dopamin-D3-reseptör afinitesine sahip triazol bileşikleri.
EA200300628A1 (ru) Соединения, специфические к аденозиновому a, aи aрецептору, и их применение
MY119031A (en) Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
CY1107637T1 (el) Θεραπευτικη αγωγη καρκινου προστατη με αντισωματα αντι - erbb2
TR200000928T2 (tr) Yeni kombinasyon.
TR200101895T2 (tr) Cinsel rahatsızlıkların tedavisi.
SE9701162D0 (sv) New use II
TR199802769T2 (tr) Terpenoid bilesikler ile antihistaminik bilesiklerin bir kombinasyonunu ihtiva eden topikal bilesim.
TR200200673T2 (tr) Rinovirüs enfeksiyonlarında csaıd&#39;lerin kullanılması
TR200001040T2 (tr) Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı
TR200100455T2 (tr) Nimesulid içeren topikal farmasötik bileşimler
TR200102742T2 (tr) Rezorsinol türevleri
DE69117303D1 (de) Zusammensetzung mit psyllium
TR200200246T2 (tr) Nezle ve grip benzeri hastalıklar ile ilişkilendirilen semptomlardan korunma ve bunların tedavisi ile ilgili bileşim.
DE69905468D1 (de) Sporizide zusammensetzung
TR200102944T2 (tr) İntegrin reseptör ligandları
MXPA02012911A (es) Compuestos de rutenio (ii) para el uso en terapia del cancer.